IsraelTuberculosis profile
Population  2014 7.9 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.014 (0.013–0.014) 0.17 (0.17–0.18)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.03 (0.02–0.03)
Prevalence  (includes HIV+TB) 0.56 (0.24–1) 7.1 (3–13)
Incidence  (includes HIV+TB) 0.46 (0.4–0.52) 5.8 (5.1–6.6)
Incidence (HIV+TB only) 0.032 (0.028–0.037) 0.41 (0.36–0.46)
         
Case detection, all forms (%) 78 (69–90)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 6.6 (3.5–11) 50 (6.8–93)
MDR-TB cases among notified pulmonary
TB cases
17 (9–28) 3 (0–6)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 200   4
Pulmonary, clinically diagnosed 58   2
Extrapulmonary 97   0
       
Total new and relapse 361    
Previously treated, excluding relapses 0    
Total cases notified 361    
Among 368 new and relapse cases:
31 (8%) cases aged under 15 years; male:female ratio: 1.7
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 257 (129%) 4 (67%) 261
Laboratory-confirmed RR-/MDR-TB cases     17
Patients started on MDR-TB treatment ***     17
TB/HIV 2014 Number (%)
TB patients with known HIV status 367 (102)
HIV-positive TB patients 25 (7)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (84) 305
Previously treated cases, excluding relapse, registered in 2013   0
HIV-positive TB cases, all types, registered in 2013 (71) 14
RR-/MDR-TB cases started on second-line treatment in 2012 (92) 13
XDR-TB cases started on second-line treatment in 2012 (100) 4
Laboratories 2014  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2015  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-09-25 Data: www.who.int/tb/data